Double-blind, placebo controlled randomized study of co-administering testosterone with PDE5 [phosphodiesterase V] inhibitors in patients non-responders to PDE5 inhibitors alone
Phase of Trial: Phase III
Latest Information Update: 17 Apr 2013
At a glance
- Drugs Testosterone (Primary) ; Tadalafil
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Acronyms TADTEST
- 27 Dec 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004081).
- 08 May 2009 Results presented at the 104th Annual Meeting of the American Urological Association (AUA), 2009.
- 24 Aug 2008 Actual patient number (173) added as reported by ClinicalTrials.gov.